{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T23:55:09Z","timestamp":1784678109204,"version":"3.55.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":309,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP17pc0101006"],"award-info":[{"award-number":["JP17pc0101006"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP17pc0101006"],"award-info":[{"award-number":["JP17pc0101006"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023368","name":"Eisai Co., Ltd.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023368","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Keio University School of Medicine"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>X-linked female-restricted neurodegenerative disorder with Parkinsonian syndrome and cognitive impairment (NDPACX) is a recently recognized clinical entity caused by heterozygous mutations in SLC9A6 on the X chromosome, which encodes the endosomal Na\u207a\/H\u207a exchanger NHE6 that contributes to endolysosomal trafficking and acidification. While hemizygous SLC9A6 mutations in males cause Christianson syndrome, a severe neurodevelopmental disorder, emerging evidence indicates that female carriers may develop progressive, adult-onset Parkinsonian syndrome variably accompanied by cognitive decline and psychiatric symptoms. These features often resemble those of corticobasal degeneration, progressive supranuclear palsy, and atypical Parkinson\u2019s disease. Although pathological data for NDPACX are currently lacking, mechanistic inferences drawn from Christianson syndrome and animal models implicate endosomal dysfunction, impaired receptor recycling, and tau accumulation, depending on the loss of function. Furthermore, recent findings have linked reduced SLC9A6 expression to the increased vulnerability of the substantia nigra in sporadic Parkinson\u2019s disease, suggesting a broader relevance beyond rare monogenic disorders. In particular, NDPACX represents a model of endolysosomal neurodegeneration that may be related to lysosomal storage diseases or autophagy-related mechanisms commonly implicated in Parkinsonian syndromes. In this review, we summarize the clinical, molecular, and emerging pathological insights into NDPACX and propose that targeting endolysosomal homeostasis may open new therapeutic avenues for both hereditary and idiopathic neurodegenerative diseases characterized by proteinopathies.<\/jats:p>","DOI":"10.1093\/braincomms\/fcaf435","type":"journal-article","created":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T04:09:46Z","timestamp":1762661386000},"source":"Crossref","is-referenced-by-count":1,"title":["NDPACX: a newly defined X-linked Parkinsonian syndrome associated with\n                    <i>SLC9A6<\/i>\n                    hemizygote mutation"],"prefix":"10.1093","volume":"7","author":[{"given":"Ryotaro","family":"Okochi","sequence":"first","affiliation":[{"name":"Department of Neurology, Keio University School of Medicine , Tokyo 160-8582 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Nihei","sequence":"additional","affiliation":[{"name":"Department of Neurology, Keio University School of Medicine , Tokyo 160-8582 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4740-1675","authenticated-orcid":false,"given":"Daisuke","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Neurology, Keio University School of Medicine , Tokyo 160-8582 ,","place":["Japan"]},{"name":"Memory Center, Keio University School of Medicine , Tokyo 160-8582 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"issue":"10","key":"2025120402514973500_fcaf435-B1","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/jmg.36.10.759","article-title":"X linked severe mental retardation, craniofacial dysmorphology, epilepsy, ophthalmoplegia, and cerebellar atrophy in a large South African kindred is localised to Xq24-q27","volume":"36","author":"Christianson","year":"1999","journal-title":"J Med Genet"},{"issue":"2","key":"2025120402514973500_fcaf435-B2","first-page":"98","article-title":"Complex neurological phenotype in female carriers of NHE6 mutations","volume":"5","author":"Pescosolido","year":"2019","journal-title":"Mol Neuropsychiatry"},{"issue":"6","key":"2025120402514973500_fcaf435-B3","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1399-0004.2012.01948.x","article-title":"Novel SLC9A6 mutations in two families with Christianson syndrome","volume":"83","author":"Riess","year":"2013","journal-title":"Clin Genet"},{"issue":"5","key":"2025120402514973500_fcaf435-B4","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1093\/brain\/awq071","article-title":"A mutation affecting the sodium\/proton exchanger, SLC9A6, causes mental retardation with tau deposition","volume":"133","author":"Garbern","year":"2010","journal-title":"Brain"},{"issue":"11","key":"2025120402514973500_fcaf435-B5","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1002\/ajmg.a.33093","article-title":"Natural history of Christianson syndrome","volume":"152A","author":"Schroer","year":"2010","journal-title":"Am J Med Genet A"},{"issue":"4","key":"2025120402514973500_fcaf435-B6","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.ajhg.2008.01.013","article-title":"SLC9A6 mutations cause X-linked mental retardation, microcephaly, epilepsy, and ataxia, a phenotype mimicking angelman syndrome","volume":"82","author":"Gilfillan","year":"2008","journal-title":"Am J Hum Genet"},{"issue":"5","key":"2025120402514973500_fcaf435-B7","doi-asserted-by":"crossref","first-page":"C1031","DOI":"10.1152\/ajpcell.00420.2001","article-title":"Human Na(+)\/H(+) exchanger isoform 6 is found in recycling endosomes of cells, not in mitochondria","volume":"282","author":"Brett","year":"2002","journal-title":"Am J Physiol Cell Physiol"},{"issue":"3","key":"2025120402514973500_fcaf435-B8","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/mds.24886","article-title":"Evidence of an association between the scavenger receptor class B member 2 gene and Parkinson\u2019s disease","volume":"27","author":"Michelakakis","year":"2012","journal-title":"Mov Disord"},{"issue":"8","key":"2025120402514973500_fcaf435-B9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11910-018-0860-4","article-title":"GBA-associated Parkinson\u2019s disease and other synucleinopathies","volume":"18","author":"Gan-Or","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"10","key":"2025120402514973500_fcaf435-B10","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/ng.3955","article-title":"A meta-analysis of genome-wide association studies identifies 17 new Parkinson\u2019s disease risk loci","volume":"49","author":"Chang","year":"2017","journal-title":"Nat Genet"},{"issue":"9","key":"2025120402514973500_fcaf435-B11","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ng.3043","article-title":"Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson\u2019s disease","volume":"46","author":"Nalls","year":"2014","journal-title":"Nat Genet"},{"issue":"2","key":"2025120402514973500_fcaf435-B12","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1074\/jbc.M410041200","article-title":"Four Na+\/H+exchanger isoforms are distributed to Golgi and post-Golgi compartments and are involved in organelle pH regulation","volume":"280","author":"Nakamura","year":"2005","journal-title":"J Biol Chem"},{"issue":"4","key":"2025120402514973500_fcaf435-B13","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1152\/physrev.00028.2018","article-title":"The SLC9A-C mammalian Na+\/H+ exchanger family: Molecules, mechanisms, and physiology","volume":"99","author":"Pedersen","year":"2019","journal-title":"Physiol Rev"},{"issue":"5","key":"2025120402514973500_fcaf435-B14","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00424-003-1110-3","article-title":"Diversity of the mammalian sodium\/proton exchanger SLC9 gene family","volume":"447","author":"Orlowski","year":"2004","journal-title":"Pflugers Arch"},{"issue":"2","key":"2025120402514973500_fcaf435-B15","doi-asserted-by":"crossref","first-page":"C223","DOI":"10.1152\/ajpcell.00360.2004","article-title":"Evolutionary origins of eukaryotic sodium\/proton exhangers","volume":"288","author":"Brett","year":"2005","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"2025120402514973500_fcaf435-B16","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1074\/jbc.M110.159202","article-title":"Structural modeling and electron paramagnetic resonance spectroscopy of the human Na+\/H+ exchanger isoform 1, NHE1","volume":"286","author":"Nygaard","year":"2011","journal-title":"J Biol Chem"},{"issue":"52","key":"2025120402514973500_fcaf435-B17","doi-asserted-by":"crossref","first-page":"37854","DOI":"10.1074\/jbc.M705460200","article-title":"Model structure of the Na+\/H+ exchanger 1 (NHE1): Functional and clinical implications","volume":"282","author":"Landau","year":"2007","journal-title":"J Biol Chem"},{"issue":"5","key":"2025120402514973500_fcaf435-B18","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.neuron.2006.09.040","article-title":"Plasticity-induced growth of dendritic spines by exocytic trafficking from recycling endosomes","volume":"52","author":"Park","year":"2006","journal-title":"Neuron"},{"issue":"7","key":"2025120402514973500_fcaf435-B19","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1093\/brain\/awl082","article-title":"Plasticity in the human central nervous system","volume":"129","author":"Cooke","year":"2006","journal-title":"Brain"},{"issue":"1","key":"2025120402514973500_fcaf435-B20","doi-asserted-by":"crossref","first-page":"e651","DOI":"10.1212\/NXG.0000000000000651","article-title":"Novel SLC9A6 variation in female carriers with intellectual disability and atypical parkinsonism","volume":"8","author":"Nan","year":"2022","journal-title":"Neurol Genet"},{"issue":"1","key":"2025120402514973500_fcaf435-B21","doi-asserted-by":"crossref","first-page":"e200235","DOI":"10.1212\/NXG.0000000000200235","article-title":"SLC9A6-linked Parkinson syndrome in female heterozygotes is associated with PET-detectable tau pathology","volume":"11","author":"Yamamoto","year":"2025","journal-title":"Neurol Genet"},{"issue":"11","key":"2025120402514973500_fcaf435-B22","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1093\/brain\/awr250","article-title":"X-linked Angelman-like syndrome caused by Slc9a6 knockout in mice exhibits evidence of endosomal-lysosomal dysfunction","volume":"134","author":"Str\u00f8mme","year":"2011","journal-title":"Brain"},{"issue":"9","key":"2025120402514973500_fcaf435-B23","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1093\/brain\/awab467","article-title":"Early lysosome defects precede neurodegeneration with amyloid-\u03b2 and tau aggregation in NHE6-null rat brain","volume":"145","author":"Lee","year":"2022","journal-title":"Brain"},{"issue":"1","key":"2025120402514973500_fcaf435-B24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1242\/dmm.022780","article-title":"X-linked Christianson syndrome: Heterozygous female Slc9a6 knockout mice develop mosaic neuropathological changes and related behavioral abnormalities","volume":"9","author":"Sikora","year":"2016","journal-title":"Dis Model Mech"},{"issue":"17","key":"2025120402514973500_fcaf435-B25","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1212\/WNL.0b013e31828f180e","article-title":"The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease","volume":"80","author":"Gan-Or","year":"2013","journal-title":"Neurology"},{"issue":"5","key":"2025120402514973500_fcaf435-B26","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1093\/brain\/awac413","article-title":"GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson\u2019s disease","volume":"146","author":"Senkevich","year":"2023","journal-title":"Brain"},{"issue":"9","key":"2025120402514973500_fcaf435-B27","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1093\/brain\/awz205","article-title":"Arylsulfatase A, a genetic modifier of Parkinson\u2019s disease, is an \u03b1-synuclein chaperone","volume":"142","author":"Lee","year":"2019","journal-title":"Brain"},{"issue":"1","key":"2025120402514973500_fcaf435-B28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00401-025-02874-7","article-title":"LRRK2-associated Parkinson\u2019s disease does have alpha-synuclein pathology","volume":"149","author":"Dzamko","year":"2025","journal-title":"Acta Neuropathol"},{"key":"2025120402514973500_fcaf435-B29","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1038\/ncomms4828","article-title":"Mutation in VPS35 associated with Parkinson\u2019s disease impairs WASH complex association and inhibits autophagy","volume":"5","author":"Zavodszky","year":"2014","journal-title":"Nat Commun"},{"issue":"7795","key":"2025120402514973500_fcaf435-B30","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41586-020-1968-7","article-title":"ATP13A2 deficiency disrupts lysosomal polyamine export","volume":"578","author":"van Veen","year":"2020","journal-title":"Nature"},{"issue":"7565","key":"2025120402514973500_fcaf435-B31","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nature14893","article-title":"The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy","volume":"524","author":"Lazarou","year":"2015","journal-title":"Nature"},{"issue":"8","key":"2025120402514973500_fcaf435-B32","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1523\/JNEUROSCI.2569-15.2016","article-title":"Parkin modulates endosomal organization and function of the endo-lysosomal pathway","volume":"36","author":"Song","year":"2016","journal-title":"J Neurosci"},{"issue":"6","key":"2025120402514973500_fcaf435-B33","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/BF00318566","article-title":"Paired helical filament tau (PHFtau) in niemann-pick type C disease is similar to PHFtau in Alzheimer\u2019s disease","volume":"90","author":"Auer","year":"1995","journal-title":"Acta Neuropathol"},{"key":"2025120402514973500_fcaf435-B34","doi-asserted-by":"crossref","first-page":"105360","DOI":"10.1016\/j.nbd.2021.105360","article-title":"Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis","volume":"154","author":"Root","year":"2021","journal-title":"Neurobiol Dis"},{"key":"2025120402514973500_fcaf435-B35","doi-asserted-by":"crossref","first-page":"148737","DOI":"10.1016\/j.gene.2024.148737","article-title":"Genes for endosomal pH regulators NHE6 and NHE9 are dysregulated in the substantia nigra in Parkinson\u2019s disease","volume":"927","author":"Prasad","year":"2024","journal-title":"Gene"},{"issue":"8","key":"2025120402514973500_fcaf435-B36","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00439-016-1675-5","article-title":"The expanding phenotypic spectrum of female SLC9A6 mutation carriers: A case series and review of the literature","volume":"135","author":"Sinajon","year":"2016","journal-title":"Hum Genet"},{"key":"2025120402514973500_fcaf435-B37","doi-asserted-by":"crossref","first-page":"268","DOI":"10.14802\/jmd.25054","article-title":"A cautionary note on the indication for deep brain stimulation in parkinsonism patients with SLC9A6 gene mutations","volume":"18","author":"Okusa","year":"2025","journal-title":"J Mov Disord"},{"issue":"8","key":"2025120402514973500_fcaf435-B38","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1002\/ajmg.a.37765","article-title":"A new family with an SLC9A6 mutation expanding the phenotypic spectrum of Christianson syndrome","volume":"170","author":"Masurel-Paulet","year":"2016","journal-title":"Am J Med Genet A"},{"issue":"12","key":"2025120402514973500_fcaf435-B39","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/s41573-019-0036-1","article-title":"Lysosomes as a therapeutic target","volume":"18","author":"Bonam","year":"2019","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"2025120402514973500_fcaf435-B40","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ymgme.2021.12.009","article-title":"Screening, patient identification, evaluation, and treatment in patients with Gaucher disease: Results from a Delphi consensus","volume":"135","author":"Kishnani","year":"2022","journal-title":"Mol Genet Metab"},{"key":"2025120402514973500_fcaf435-B41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejim.2016.07.011","article-title":"Management and monitoring recommendations for the use of eliglustat in adults with type 1 Gaucher disease in Europe","volume":"37","author":"Belmatoug","year":"2017","journal-title":"Eur J Intern Med"}],"container-title":["Brain Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/braincomms\/advance-article-pdf\/doi\/10.1093\/braincomms\/fcaf435\/65231950\/fcaf435.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/7\/6\/fcaf435\/65231950\/fcaf435.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/7\/6\/fcaf435\/65231950\/fcaf435.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T07:52:04Z","timestamp":1764834724000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/braincomms\/article\/doi\/10.1093\/braincomms\/fcaf435\/8315334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,10,30]]}},"URL":"https:\/\/doi.org\/10.1093\/braincomms\/fcaf435","relation":{},"ISSN":["2632-1297"],"issn-type":[{"value":"2632-1297","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"fcaf435"}}